Use of injectable progestin (medroxyprogesterone acetate) in adolescent health care.
To assess medroxyprogesterone acetate (DMPA) prescription practices in adolescent health care practices, an anonymous questionnaire was distributed to 160 American and Canadian physicians attending the 1991 meetings of either the Society for Adolescent Medicine or the North American Society for Pediatric and Adolescent Gynecology. Of 54 (33.7%) physicians who responded, 33 (61.1%) reported prior prescription of an injectable progestin (DMPA) as a form of birth control. Of those, 15 (45.5%) had prescribed it to 10 or more adolescents. Twelve (57%) pediatricians but only 3 (25%) gynecologists reported prescribing DMPA to 10 or more adolescents (p = 0.074). Female physicians were more likely to have prescribed DMPA to adolescents than male physicians (p = 0.009). Mental retardation was considered the strongest "potential indication" for DMPA administration by 48 physicians responding to a 5-point Likert scale. The study suggests that physicians with interest or expertise in Adolescent Medicine are using DMPA as a form of birth control for selected young women in spite of the lack of Food and Drug Administration approval. A centralized DMPA registry is suggested to monitor adverse outcomes in users.
Isart
F
F
Adolescent Young Adult Program, College of Medicine, University of Florida, Gainesville 32610.
Weber
F T
FT
Merrick
C L
CL
Rowe
S
S
D000328:Adult; D000368:Aged; D002170:Canada; D003271:Contraceptive Agents, Female; D004363:Drug Utilization; D005193:Family Planning Services / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000191:economics; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000191:economics; D008875:Middle Aged; D014481:United States
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate